Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Beck

Showing results (81-90 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Spinal Cord Medicine|July 16, 2021
Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and LowsAndrei Krassioukov, Todd A Linsenmeyer, Lisa A Beck, et al.
Pediatrics|March 4, 2003
Atopic dermatitis and asthma: parallels in the evolution of treatmentLawrence F Eichenfield, Jon M Hanifin, Lisa A Beck, et al.
Msphere|December 13, 2019
Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis PatientsMary C Moran, Michael P Cahill, Matthew G Brewer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2024
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitisJulie Ryan Wolf, Anita Chen, Jill Wieser, et al.
The Journal of Dermatological Treatment|February 9, 2021
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension studyLisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
Nanotoxicology|October 20, 2012
Quantification of quantum dot murine skin penetration with UVR barrier impairmentLuke J Mortensen, Samreen Jatana, Robert Gelein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Functional analysis of the chemokine receptor CCR3 on airway epithelial cellsLisa A Beck, Brian Tancowny, Mary E Brummet, et al.
JAAD Case Reports|April 8, 2020
Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatmentJill K Wieser, Gina J Kuehn, James C Prezzano, et al.
Archives of Dermatological Research|September 27, 2023
Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitisAnia Stolarczyk, Nelissa Perez-Nazario, Sara A Knowlden, et al.
Current Medical Research and Opinion|October 25, 2017
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Xuehua Ke, Abhishek Kavati, et al.
Pageof 18

Showing results (81-90 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Spinal Cord Medicine|July 16, 2021
Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and LowsAndrei Krassioukov, Todd A Linsenmeyer, Lisa A Beck, et al.
Pediatrics|March 4, 2003
Atopic dermatitis and asthma: parallels in the evolution of treatmentLawrence F Eichenfield, Jon M Hanifin, Lisa A Beck, et al.
Msphere|December 13, 2019
Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis PatientsMary C Moran, Michael P Cahill, Matthew G Brewer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2024
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitisJulie Ryan Wolf, Anita Chen, Jill Wieser, et al.
The Journal of Dermatological Treatment|February 9, 2021
Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension studyLisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
Nanotoxicology|October 20, 2012
Quantification of quantum dot murine skin penetration with UVR barrier impairmentLuke J Mortensen, Samreen Jatana, Robert Gelein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
Functional analysis of the chemokine receptor CCR3 on airway epithelial cellsLisa A Beck, Brian Tancowny, Mary E Brummet, et al.
JAAD Case Reports|April 8, 2020
Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatmentJill K Wieser, Gina J Kuehn, James C Prezzano, et al.
Archives of Dermatological Research|September 27, 2023
Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitisAnia Stolarczyk, Nelissa Perez-Nazario, Sara A Knowlden, et al.
Current Medical Research and Opinion|October 25, 2017
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Xuehua Ke, Abhishek Kavati, et al.
Pageof 18